Does the media refer more to TMO or ANGO?

In the previous week, Thermo Fisher Scientific and Thermo Fisher Scientific both had 25 articles in the media. Thermo Fisher Scientific's average media sentiment score of 1.25 beat AngioDynamics' score of 0.54 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 20 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 6 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor WST or ANGO?

In the previous week, AngioDynamics had 15 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 25 mentions for AngioDynamics and 10 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.74 beat AngioDynamics' score of 0.54 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 6 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to ANGO or SMA?

In the previous week, AngioDynamics had 22 more articles in the media than Smartstop Self Storage REIT. MarketBeat recorded 25 mentions for AngioDynamics and 3 mentions for Smartstop Self Storage REIT. AngioDynamics' average media sentiment score of 0.54 beat Smartstop Self Storage REIT's score of 0.34 indicating that AngioDynamics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 6 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Smartstop Self Storage REIT 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, ANGO or ATRC?

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AngioDynamics $320.17M 1.82 -$33.99M -$0.87 N/A AtriCure $534.53M 3.38 -$11.45M -$0.10 N/A

Is ANGO or ATRC more profitable?

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -11.48%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity. Company Net Margins Return on Equity Return on Assets AngioDynamics -11.48% -5.73% -3.77% AtriCure -0.83% 0.29% 0.22%

Does the media refer more to ANGO or ATRC?

In the previous week, AngioDynamics had 21 more articles in the media than AtriCure. MarketBeat recorded 25 mentions for AngioDynamics and 4 mentions for AtriCure. AtriCure's average media sentiment score of 0.81 beat AngioDynamics' score of 0.54 indicating that AtriCure is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 6 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive AtriCure 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ANGO or ATEC more profitable?

AngioDynamics has a net margin of -11.48% compared to Alphatec's net margin of -15.93%. AngioDynamics' return on equity of -5.73% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets AngioDynamics -11.48% -5.73% -3.77% Alphatec -15.93% -1,183.84% -15.83%

Does the media prefer ANGO or ATEC?

In the previous week, AngioDynamics had 15 more articles in the media than Alphatec. MarketBeat recorded 25 mentions for AngioDynamics and 10 mentions for Alphatec. Alphatec's average media sentiment score of 0.91 beat AngioDynamics' score of 0.54 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 6 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Alphatec 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

AngioDynamics (ANGO) Competitors

$14.14 -0.33 (-2.28%)

Closing price 04:00 PM Eastern

Extended Trading

$14.14 -0.01 (-0.04%)

As of 04:10 PM Eastern

Compare

ANGO vs. TMO, WST, SMA, ATRC, and ATEC

Should you buy AngioDynamics stock or one of its competitors? MarketBeat compares AngioDynamics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), and Alphatec (ATEC).

How does AngioDynamics compare to Thermo Fisher Scientific?

Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Thermo Fisher Scientific has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.34, suggesting that its stock price is 66% less volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$45.20B	4.47	$6.70B	$18.19	29.91
AngioDynamics	$320.17M	1.82	-$33.99M	-$0.87	N/A

Thermo Fisher Scientific has a net margin of 15.15% compared to AngioDynamics' net margin of -11.48%. Thermo Fisher Scientific's return on equity of 16.86% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.15%	16.86%	8.15%
AngioDynamics	-11.48%	-5.73%	-3.77%

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 6.0% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Thermo Fisher Scientific currently has a consensus target price of $602.14, indicating a potential upside of 10.68%. AngioDynamics has a consensus target price of $19.50, indicating a potential upside of 38.20%. Given AngioDynamics' higher possible upside, analysts plainly believe AngioDynamics is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.84
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

In the previous week, Thermo Fisher Scientific and Thermo Fisher Scientific both had 25 articles in the media. Thermo Fisher Scientific's average media sentiment score of 1.25 beat AngioDynamics' score of 0.54 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	20 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Thermo Fisher Scientific beats AngioDynamics on 13 of the 16 factors compared between the two stocks.

How does AngioDynamics compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

In the previous week, AngioDynamics had 15 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 25 mentions for AngioDynamics and 10 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.74 beat AngioDynamics' score of 0.54 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

West Pharmaceutical Services has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.34, indicating that its stock price is 66% less volatile than the broader market.

West Pharmaceutical Services presently has a consensus target price of $363.17, indicating a potential upside of 0.30%. AngioDynamics has a consensus target price of $19.50, indicating a potential upside of 38.20%. Given AngioDynamics' higher probable upside, analysts plainly believe AngioDynamics is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

West Pharmaceutical Services has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.22B	7.94	$493.70M	$7.48	48.41
AngioDynamics	$320.17M	1.82	-$33.99M	-$0.87	N/A

West Pharmaceutical Services has a net margin of 16.85% compared to AngioDynamics' net margin of -11.48%. West Pharmaceutical Services' return on equity of 19.03% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
AngioDynamics	-11.48%	-5.73%	-3.77%

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

West Pharmaceutical Services beats AngioDynamics on 14 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to Smartstop Self Storage REIT?

AngioDynamics (NASDAQ:ANGO) and Smartstop Self Storage REIT (NYSE:SMA) are both small-cap health care equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Smartstop Self Storage REIT has lower revenue, but higher earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$320.17M	1.82	-$33.99M	-$0.87	N/A
Smartstop Self Storage REIT	$294.00M	6.59	-$1.55M	$0.15	233.43

In the previous week, AngioDynamics had 22 more articles in the media than Smartstop Self Storage REIT. MarketBeat recorded 25 mentions for AngioDynamics and 3 mentions for Smartstop Self Storage REIT. AngioDynamics' average media sentiment score of 0.54 beat Smartstop Self Storage REIT's score of 0.34 indicating that AngioDynamics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Smartstop Self Storage REIT	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Smartstop Self Storage REIT has a net margin of 4.38% compared to AngioDynamics' net margin of -11.48%. Smartstop Self Storage REIT's return on equity of 1.00% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-11.48%	-5.73%	-3.77%
Smartstop Self Storage REIT	4.38%	1.00%	0.54%

AngioDynamics has a beta of 0.34, suggesting that its share price is 66% less volatile than the broader market. Comparatively, Smartstop Self Storage REIT has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

AngioDynamics currently has a consensus price target of $19.50, suggesting a potential upside of 38.20%. Smartstop Self Storage REIT has a consensus price target of $36.31, suggesting a potential upside of 3.71%. Given AngioDynamics' higher possible upside, equities analysts plainly believe AngioDynamics is more favorable than Smartstop Self Storage REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.70

89.4% of AngioDynamics shares are owned by institutional investors. 6.0% of AngioDynamics shares are owned by company insiders. Comparatively, 5.7% of Smartstop Self Storage REIT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Smartstop Self Storage REIT beats AngioDynamics on 11 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to AtriCure?

AngioDynamics (NASDAQ:ANGO) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -11.48%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-11.48%	-5.73%	-3.77%
AtriCure	-0.83%	0.29%	0.22%

AngioDynamics currently has a consensus price target of $19.50, indicating a potential upside of 38.20%. AtriCure has a consensus price target of $48.71, indicating a potential upside of 36.63%. Given AngioDynamics' higher possible upside, research analysts clearly believe AngioDynamics is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

89.4% of AngioDynamics shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 6.0% of AngioDynamics shares are owned by company insiders. Comparatively, 4.0% of AtriCure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$320.17M	1.82	-$33.99M	-$0.87	N/A
AtriCure	$534.53M	3.38	-$11.45M	-$0.10	N/A

In the previous week, AngioDynamics had 21 more articles in the media than AtriCure. MarketBeat recorded 25 mentions for AngioDynamics and 4 mentions for AtriCure. AtriCure's average media sentiment score of 0.81 beat AngioDynamics' score of 0.54 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
AtriCure	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AngioDynamics has a beta of 0.34, indicating that its share price is 66% less volatile than the broader market. Comparatively, AtriCure has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market.

Summary

AtriCure beats AngioDynamics on 12 of the 16 factors compared between the two stocks.

How does AngioDynamics compare to Alphatec?

AngioDynamics (NASDAQ:ANGO) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

89.4% of AngioDynamics shares are owned by institutional investors. Comparatively, 66.3% of Alphatec shares are owned by institutional investors. 6.0% of AngioDynamics shares are owned by insiders. Comparatively, 13.5% of Alphatec shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, AngioDynamics had 15 more articles in the media than Alphatec. MarketBeat recorded 25 mentions for AngioDynamics and 10 mentions for Alphatec. Alphatec's average media sentiment score of 0.91 beat AngioDynamics' score of 0.54 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Alphatec	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AngioDynamics has a beta of 0.34, indicating that its share price is 66% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market.

AngioDynamics has a net margin of -11.48% compared to Alphatec's net margin of -15.93%. AngioDynamics' return on equity of -5.73% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-11.48%	-5.73%	-3.77%
Alphatec	-15.93%	-1,183.84%	-15.83%

AngioDynamics currently has a consensus price target of $19.50, indicating a potential upside of 38.20%. Alphatec has a consensus price target of $17.46, indicating a potential upside of 88.88%. Given Alphatec's stronger consensus rating and higher probable upside, analysts clearly believe Alphatec is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85

AngioDynamics has higher earnings, but lower revenue than Alphatec. AngioDynamics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$320.17M	1.82	-$33.99M	-$0.87	N/A
Alphatec	$787.08M	1.81	-$143.36M	-$0.82	N/A

Summary

Alphatec beats AngioDynamics on 9 of the 16 factors compared between the two stocks.

Get AngioDynamics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ANGO vs. The Competition

Export

Metric	AngioDynamics	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$583.01M	$7.57B	$6.86B	$12.44B
Dividend Yield	N/A	1.31%	2.68%	9.44%
P/E Ratio	-16.22	50.61	27.16	24.25
Price / Sales	1.82	92.96	510.61	87.66
Price / Cash	41.55	26.20	48.63	60.03
Price / Book	3.42	7.22	10.78	6.23
Net Income	-$33.99M	$162.30M	$3.59B	$331.94M
7 Day Performance	9.21%	-1.04%	-2.58%	-1.97%
1 Month Performance	16.13%	-0.08%	2.76%	-1.00%
1 Year Performance	64.07%	6.89%	25.34%	18.13%

AngioDynamics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ANGO AngioDynamics	3.7667 of 5 stars	$14.14 -2.3%	$19.50 +37.9%	+67.3%	$584.25M	$320.17M	N/A	760	Trending News Earnings Report Analyst Forecast Analyst Revision High Trading Volume
TMO Thermo Fisher Scientific	4.379 of 5 stars	$518.85 +0.2%	$601.61 +16.0%	+28.1%	$193.53B	$44.56B	28.63	125,000	Positive News Upcoming Earnings Dividend Announcement Analyst Upgrade
WST West Pharmaceutical Services	2.9364 of 5 stars	$357.37 -0.1%	$351.91 -1.5%	+62.4%	$25.37B	$3.07B	48.00	10,800	Upcoming Earnings Analyst Forecast
SMA Smartstop Self Storage REIT	1.8612 of 5 stars	$33.07 +0.8%	$36.81 +11.3%	-8.9%	$1.83B	$281.14M	220.13	N/A	Analyst Forecast
ATRC AtriCure	3.6699 of 5 stars	$32.75 +1.1%	$48.71 +48.8%	+13.1%	$1.66B	$534.53M	N/A	1,300	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ANGO) was last updated on 7/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and ATEC

How does AngioDynamics compare to Thermo Fisher Scientific?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Summary

How does AngioDynamics compare to AtriCure?

Summary

How does AngioDynamics compare to Alphatec?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and ATEC

How does AngioDynamics compare to Thermo Fisher Scientific?

Which has more risk and volatility, TMO or ANGO?

Which has better valuation & earnings, TMO or ANGO?

Is TMO or ANGO more profitable?

Do insiders & institutionals believe in TMO or ANGO?

Do analysts prefer TMO or ANGO?

Does the media refer more to TMO or ANGO?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Does the media favor WST or ANGO?

Which has more volatility & risk, WST or ANGO?

Do analysts rate WST or ANGO?

Which has higher earnings and valuation, WST or ANGO?

Is WST or ANGO more profitable?

Do insiders & institutionals have more ownership in WST or ANGO?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Which has preferable earnings and valuation, ANGO or SMA?

Does the media refer more to ANGO or SMA?

Is ANGO or SMA more profitable?

Which has more risk and volatility, ANGO or SMA?

Do analysts prefer ANGO or SMA?

Do insiders & institutionals hold more shares of ANGO or SMA?

Summary

How does AngioDynamics compare to AtriCure?

Is ANGO or ATRC more profitable?

Do analysts prefer ANGO or ATRC?

Do institutionals and insiders believe in ANGO or ATRC?

Which has preferable valuation & earnings, ANGO or ATRC?

Does the media refer more to ANGO or ATRC?

Which has more volatility & risk, ANGO or ATRC?

Summary

How does AngioDynamics compare to Alphatec?

Do institutionals & insiders believe in ANGO or ATEC?

Does the media prefer ANGO or ATEC?

Which has more volatility and risk, ANGO or ATEC?

Is ANGO or ATEC more profitable?

Do analysts recommend ANGO or ATEC?

Which has stronger earnings & valuation, ANGO or ATEC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools